<DOC>
	<DOCNO>NCT01849341</DOCNO>
	<brief_summary>It phase IV clinical trial : longitudinal , prospective , evaluator-blind , randomize 2 group patient chronic obstructive pulmonary disease ( COPD ) . The intervention group base administration roflumilast 500 mcg per day alternate day ( roflumilast 500μg eod ) 2 week ( phase ) . In control group assign undertake treatment accord standard dosage ( roflumilast 500μg od ) . The patient monitoring do one sub-investigators fully independent team start medication keep pattern mask single blind , since aim assess frequency adverse event ( AEs ) group collect systematically different AEs characteristic 15 day ( V1 ) , moment month ( V2 ) 2 month ( V3 ) . Likewise , data collect ( functional demographic , comorbidities , home treatment , anxiety depression quality life ) . The purpose study ass whether administration roflumilast gradual pattern varies incidence discontinuation due adverse event compare usual dosage .</brief_summary>
	<brief_title>Roflumilast Safety Administered Once Day Alternate Days Two Weeks Compared Usual Dosage Once Daily</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Diagnosis COPD severe degree GOLD criterion , assess postbronchodilator spirometry ( FEV1 &lt; 50 % , FEV1/Forced vital capacity ( FVC ) &lt; 70 % theory ) . Age 18 year . Productive cough recurrently day least three month year least 2 consecutive year . History smoke prior &gt; 15 20 pack / year . An exacerbation previous year . Stability clinic last 30 day . Pregnancy / breastfeeding . Acute infection . Patients severe mental disorder uncontrolled , opinion investigator , would make patient high risk due participation study , could confound factor study 's result likely prevent patient meet requirement study complete study . Patients cachectic risk cachexia . HIV infection . Severe immune Infections ( systemic lupus erythematosus , multiple sclerosis , etc. ) . Gastroesophageal reflux symptom diagnosis establish . Hiatal hernia . Peptic ulcer disease . Inflammatory bowel pathology . Neoplastic pathology : current diagnosis cancer basal cell squamous cell carcinoma skin . Moderate severe hepatic impairment ( ChildPugh BC ) . Inability understand / perform technique . Home treatment theophylline , methotrexate , azathioprine , infliximab , etanercept , inducer cytochrome P450 ( eg , rifampicin , phenobarbital , carbamazepine , phenytoin ) , cytochrome P450 3A4 ( CYP3A4 ) inhibitor ( erythromycin ketoconazole ) , oral contraceptive ( gestodene ethinyl estradiol ) , make prolonged oral corticosteroid , drug contains fluvoxamine , enoxacin cimetidine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>COPD</keyword>
</DOC>